We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-3.77%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$263M
AUM Growth
-$43.9M
Cap. Flow
-$16.6M
Cap. Flow %
-6.31%
Top 10 Hldgs %
74.4%
Holding
80
New
21
Increased
6
Reduced
17
Closed
28

Sector Composition

Rank Sector Weight
1 Communication Services 44.55%
2 Technology 12.09%
3 Financials 6.08%
4 Healthcare 5.14%
5 Consumer Discretionary 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAGE
26
DELISTED
WageWorks, Inc.
WAGE
$1.71M 0.65%
26,469
-87,122
-77% -$4.86M
XLRN
27
DELISTED
Acceleron Pharma
XLRN
$1.66M 0.63%
+42,549
New +$1.48M
GPRO icon
28
GoPro
GPRO
$121M
$1.62M 0.62%
+25,626
New +$1.89M
CRM icon
29
Salesforce
CRM
$149B
$1.46M 0.56%
24,686
-11,757
-32% -$693K
IMDZ
30
DELISTED
Immune Design Corp.
IMDZ
$1.32M 0.5%
+42,812
New +$1.19M
RNG icon
31
RingCentral
RNG
$4.64B
$1.22M 0.46%
81,463
-145,712
-64% -$1.83M
VTLE
32
DELISTED
Vital Energy
VTLE
$1.08M 0.41%
5,224
-4,000
-43% -$1.21M
TVRD
33
Tvardi Therapeutics
TVRD
$19.1M
$795K 0.3%
2,214
-278
-11% -$89.5K
SALE
34
DELISTED
RetailMeNot, Inc. Series 1
SALE
$700K 0.27%
47,899
AERI
35
DELISTED
Aerie Pharmaceuticals
AERI
$685K 0.26%
23,475
-38,605
-62% -$979K
JD icon
36
JD.com
JD
$44.1B
$611K 0.23%
+26,393
New +$650K
ARDX icon
37
Ardelyx
ARDX
$1.24B
$594K 0.23%
+31,463
New +$729K
NKTR icon
38
Nektar Therapeutics
NKTR
$2.38B
$565K 0.21%
+2,431
New +$520K
MKTO
39
DELISTED
MARKETO INC COM STK (DE)
MKTO
$551K 0.21%
+16,853
New +$531K
ZEN
40
DELISTED
ZENDESK INC
ZEN
$534K 0.2%
+21,893
New +$515K
RKUS
41
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$455K 0.17%
37,887
MCEP
42
DELISTED
Mid-Con Energy Partners, LP
MCEP
$398K 0.15%
3,154
CVT
43
DELISTED
CVENT, INC.
CVT
$336K 0.13%
+12,084
New +$316K
MGNX icon
44
MacroGenics
MGNX
$234M
$323K 0.12%
+9,201
New +$229K
MVNR
45
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
$299K 0.11%
+22,050
New +$268K
ALIM
46
DELISTED
Alimera Sciences
ALIM
$240K 0.09%
2,886
+1,553
+117% +$126K
RCPT
47
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$239K 0.09%
1,952
-5,385
-73% -$545K
HSTO
48
DELISTED
Histogen Inc. Common Stock
HSTO
$232K 0.09%
166
TSLA icon
49
Tesla
TSLA
$1.21T
$230K 0.09%
15,540
TOVX icon
50
Theriva Biologics
TOVX
$9.44M
$35K 0.01%
+3
New +$40.3K

Similar funds

Hamilton Lane Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Hamilton Lane Advisors held 80 positions worth $263M, down 14% from $307M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Hamilton Lane Advisors withdrew a net $16.6M in Q4 2014, closing 28 positions and reducing 17 holdings. Its most notable exit was Mandiant, Inc. Common Stock, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 45% of assets, down from 49% a quarter earlier, followed by Technology and Financials.

Against the trend, Hamilton Lane Advisors opened a new position in Logan Ridge Finance Corp worth $8.3M.

  • Hamilton Lane Advisors's largest Q4 2014 buy was Logan Ridge Finance Corp: 77,467 shares worth $8.3M.
  • Hamilton Lane Advisors added most to Meta Platforms (Facebook) in Q4 2014, an estimated $48.2M increase.
  • Hamilton Lane Advisors's biggest Q4 2014 reduction was Twitter, Inc., cutting an estimated $54.3M.
  • Hamilton Lane Advisors fully exited Mandiant, Inc. Common Stock in Q4 2014, selling an estimated $5.82M.
  • Hamilton Lane Advisors's ten largest holdings make up 74% of its $263M portfolio in Q4 2014.
  • Hamilton Lane Advisors opened 21 new positions and closed 28 in Q4 2014.
  • Hamilton Lane Advisors's portfolio value fell 14% quarter-over-quarter to $263M.

Based on Hamilton Lane Advisors's 13F filing for Q4 2014, filed 26 Jan 2015.